Diabetic Foot Ulcers Treatment Market

Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the patients with diabetes mellitus and diabetes insipidus, which also leads to chronic foot wounds due to minor trauma or pressure.

Diabetic Foot Ulcers Treatment Market contains market size and forecasts of Diabetic Foot Ulcers Treatment in global, including the following market information:

Global Diabetic Foot Ulcers Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Diabetic Foot Ulcers Treatment Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Diabetic Foot Ulcers Treatment companies in 2021 (%)

The global Diabetic Foot Ulcers Treatment market was valued at 5416.8 million in 2021 and is projected to reach US$ 9617 million by 2028, at a CAGR of 8.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Foot Ulcers Treatment include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc, Smith & Nephew Plc, Medtronic Plc, ConvaTec Inc, Molnlycke Health Care and Organogenesis, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diabetic Foot Ulcers Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Foot Ulcers Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, by Type, 2021 (%)

• Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings)
• Biologics (Growth factors, and Skin Graft and Skin Substitute)
• Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices)

Global Diabetic Foot Ulcers Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Ambulatory Surgical Center
• Homecare Setting

Global Diabetic Foot Ulcers Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetic Foot Ulcers Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Diabetic Foot Ulcers Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Diabetic Foot Ulcers Treatment revenues share in global market, 2021 (%)
• Key companies Diabetic Foot Ulcers Treatment sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Diabetic Foot Ulcers Treatment sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3M Healthcare
• Coloplast A/S
• B.Braun Melsungen AG
• Acelity L.P. Inc
• Smith & Nephew Plc
• Medtronic Plc
• ConvaTec Inc
• Molnlycke Health Care
• Organogenesis, Inc.
• Derma Sciences Inc.
• Sigvaris Inc.